The HDAC2-SP1 Axis Orchestrates Protumor Macrophage Polarization

Area of Science:

• Immunology
• Epigenetics
• Oncology

Background:

• Tumor-associated macrophages (TAMs) play critical roles in lung cancer, with M2-like TAMs promoting tumor growth.
• Epigenetic regulators, such as histone deacetylase 2 (HDAC2), are crucial in determining macrophage phenotype within the tumor microenvironment.

Purpose of the Study:

• To investigate the role of HDAC2 in M2-like TAMs and its impact on lung cancer progression.
• To evaluate the therapeutic potential of targeting HDAC2 in TAMs for lung cancer treatment.

Main Methods:

• Analysis of HDAC2 expression in lung cancer patient samples and correlation with survival.
• In vitro coculture systems with TAMs and lung cancer cells to assess the effects of HDAC2 suppression.
• In vivo studies using murine lung cancer models with myeloid cell-specific Hdac2 deletion or pharmacologic HDAC inhibition.

Main Results:

• High HDAC2 expression in M2-like TAMs correlates with poor lung cancer patient survival.
• HDAC2 suppression in TAMs shifted macrophage phenotype, reduced cancer cell proliferation and migration, and inhibited angiogenesis.
• Targeting HDAC2 in vivo reversed protumor TAM phenotypes, promoted anti-tumor immune cell infiltration, and suppressed tumor growth.

Conclusions:

• HDAC2 in TAMs is a key epigenetic regulator driving M2-like polarization and promoting lung cancer.
• Targeting HDAC2 in TAMs represents a promising therapeutic strategy to reprogram the tumor microenvironment and inhibit lung cancer progression.